FDA Orange Book · active-ingredient family
Ifosfamide; mesna
Ifosfamide; mesna is approved as 1 brand and 1 generic application in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:IFEX/MESNEX KIT · NDA 019763
1
Brand (NDA)
1
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| IFEX/MESNEX KIT×2 | BAXTER HLTHCARE | NDA 019763 | — | Oct 10, 1992 |
Generic (ANDA) products (1)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| IFOSFAMIDE/MESNA KIT×2 | TEVA PHARMS USA | ANDA 075874 | — | Feb 26, 2002 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Ifosfamide; mesna — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

